New Key Statistics Module, Z-Score and F-Score
OTCPK:CLPBY Key Ratios
| Market Cap $ M | 15,122.13 |
| Enterprise Value $ M | 18,645.09 |
| P/E(ttm) | 45.96 |
| PE Ratio without NRI | 18.33 |
| Forward PE Ratio | 16.38 |
| Price/Book | 7.71 |
| Price/Sales | 3.49 |
| Price/Free Cash Flow | 16.63 |
| Price/Owner Earnings | 18.88 |
| Payout Ratio % | 0.98 |
| Revenue (TTM) $ M | 4,370.00 |
| EPS (TTM) $ | 0.15 |
| Beneish M-Score | -3.23 |
| 10-y EBITDA Growth Rate % | 11.00 |
| 5-y EBITDA Growth Rate % | 4.50 |
| y-y EBITDA Growth Rate % | 0.40 |
| EV-to-EBIT | 26.59 |
| EV-to-EBITDA | 13.36 |
| PEG | 4.07 |
| Shares Outstanding M | 2,253.67 |
| Net Margin (%) | 7.51 |
| Operating Margin % | 26.88 |
| Pre-tax Margin (%) | 12.28 |
| Quick Ratio | 1.09 |
| Current Ratio | 1.75 |
| ROA % (ttm) | 4.37 |
| ROE % (ttm) | 13.83 |
| ROIC % (ttm) | 10.52 |
| Dividend Yield % | 5.36 |
| Altman Z-Score | 3.04 |
CLPBY Number of Guru Trades
CLPBY Volume of Guru Trades
Gurus Latest Trades with OTCPK:CLPBY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CLPBY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Coloplast AS Insider Transactions
No Available Data
News about OTCPK:CLPBY
Total 0- 1